Skip to content

Comparison of Temperatures Administered Remimazolam or Propofol

Comparison of Temperatures Administered Remimazolam or Propofol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111277
Enrollment
Unknown
Registered
2025-10-29
Start date
2025-11-02
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological Laparoscopic Surgery

Interventions

Remimazolam Group:Remimazolam is used for anesthesia induction and maintenance.
Propofol Group:Propofol is used for anesthesia induction and maintenance.

Sponsors

Department of Anesthesiology, The First Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Gynecological oncology patients aged 18 and above who are scheduled to undergo laparoscopic surgery under general anesthesia at The First Affiliated Hospital of Sun Yat-sen University, with an expected operation time of more than 3 hours.

Exclusion criteria

Exclusion criteria: 1. Suffering from thyroid disease, peripheral vascular disease, or renal insufficiency requiring dialysis; 2. Having a body temperature 38°C during preoperative hospitalization; 3. Known allergy to remimazolam or propofol; 4. Body Mass Index (BMI) > 30 kg/m^2; 5. Patients refusing to participate in this study.

Design outcomes

Primary

MeasureTime frame
Core body temperature 1 hour after anesthesia induction;

Secondary

MeasureTime frame
Intraoperative core body temperature;

Countries

China

Contacts

Public ContactJiang Nan

The First Affiliated Hospital of Sun Yat-sen University

jnan@mail.sysu.edu.cn+86 136 6045 7579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026